Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing research and development investments
3.2.1.2 Increasing prevalence of cancer
3.2.1.3 Increasing adoption of precision medicine approaches
3.2.1.4 Rising burden of adverse drug reactions
3.2.2 Industry pitfalls & challenges
3.2.2.1 Cost and reimbursement challenges
3.2.2.2 Complexity and interpretation of genetic data
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Offering, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Kits & reagents
5.2.1 Sequencing kits & reagents
5.2.2 PCR kits & reagents
5.2.3 Microarray kits & reagents
5.2.4 Other kits & reagents
5.3 Service
Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Sequencing
6.3 PCR
6.4 Microarray
6.5 Other technologies
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Personalized medicine
7.3 Clinical research
7.4 Drug discovery and preclinical development
Chapter 8 Market Estimates and Forecast, By Disease Area, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Oncology
8.3 Cardiovascular disorders
8.4 Neurological diseases
8.5 Infectious diseases
8.6 Mental health
8.7 Other disease areas
Chapter 9 Market Estimates and Forecast, By End-User, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Hospitals & clinics
9.3 Academic & research institutes
9.4 Pharmaceutical & biotechnology companies
9.5 CROs
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Agilent Technologies Inc.
11.2 Becton, Dickinson and Company
11.3 Bio-Rad Laboratories Inc.
11.4 Charles River Laboratories
11.5 Danaher Corporation
11.6 Eurofins Scientific
11.7 F. Hoffmann-La Roche Ltd
11.8 Illumina Inc.
11.9 Laboratory Corporation of America Holdings
11.10 Mesa Labs, Inc.
11.11 Novogene Co., Ltd.
11.12 Revvity
11.13 Qiagen N.V.
11.14 Takara Bio Inc.
11.15 Thermo Fisher Scientific Inc.
